Dr. Lal Pathlabs Ltd.

NSE: LALPATHLAB | BSE: 539524 | ISIN: INE600L01024 | Industry: Healthcare Services
| Expensive Rocket
2006.0000 42.80 (2.18%)
NSE Nov 20, 2026 15:31 PM
Volume: 265.0K
 

2006.00
2.18%
Emkay
Following the slump in FY23, DLPL has registered revenue/EBITDA/PAT CAGR of 10%/19%/43%, respectively, over the last two years.
Number of FII/FPI investors increased from 357 to 427 in Sep 2026 qtr.
More from Dr. Lal Pathlabs Ltd.
Recommended